0
0
HYDERABAD, Telangana – April 22, 2025 – Malla Reddy Narayana Cancer Hospital in Suraram, Hyderabad, has announced a significant medical achievement, reporting the successful treatment of what is believed to be India’s first case of Primary Peritoneal Ewing’s Sarcoma using a complex procedure involving Cytoreductive Surgery (CRS) followed by Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
The announcement was made during a press meet held at the hospital premises on April 21st. The landmark case involved 24-year-old Gautham Kumar, who arrived at Malla Reddy Narayana after undergoing two previous rounds of chemotherapy at another institution. He was diagnosed with Primary Peritoneal Ewing’s Sarcoma, an exceptionally rare and aggressive cancer not typically found in the peritoneum (the lining of the abdominal cavity).
A multidisciplinary oncology team, led by Senior Consultant Surgical Oncologist Dr. Harish Dara, undertook the demanding treatment. The core of the intervention was a marathon 16-hour surgery that combined CRS – the meticulous removal of all visible tumour tissue – with the immediate administration of HIPEC.
HIPEC involves circulating heated chemotherapy drugs directly within the patient’s abdominal cavity during the surgery. This advanced technique aims to destroy any remaining microscopic cancer cells, improve the absorption of the chemotherapy drugs, and limit damage to surrounding healthy tissues compared to traditional systemic chemotherapy.
“This case represents the best of surgical innovation and team collaboration,” commented Dr. Harish Dara. “When combined with complete cytoreduction, HIPEC can offer patients a real chance at long-term survival in situations where traditional treatment options fall short.”
The complexity and length of the surgery required exceptional coordination. Dr. G. Narendra Prakash, Senior Anaesthetist, noted, “The success of this high-risk surgery required seamless coordination across multiple departments. Intraoperative stability was critical, and we ensured continuous monitoring and management throughout the extended duration of the procedure.”
Hospital leadership emphasized the significance of the achievement. Dr. Ch. Preethi Reddy, Vice-Chairman of Malla Reddy Vishwavidyapeeth, stated, “Treating Primary Peritoneal Ewing’s Sarcoma with advanced HIPEC is extremely rare–both globally and in India–due to the rarity of the disease and the specialized nature of the treatment. It demands highly skilled surgeons, specialized infrastructure, and a dedicated multidisciplinary team. Malla Reddy Narayana Cancer Hospital stands among India’s leading advanced cancer centres.”
Dr. Ch. Bhadra Reddy, Chairman of Malla Reddy Vishwavidyapeeth, added, “This extraordinary case reflects our ongoing mission to bring advanced and accessible cancer care to the region. We continue to invest in infrastructure, technology, and expertise that allow us to manage even the rarest and most challenging cases with confidence and care.”
Malla Reddy Narayana Cancer Hospital highlights that the HIPEC procedure, now available at their facility, represents a major advancement not only for rare sarcomas but also for treating other abdominal cancers like ovarian, colorectal, and gastric cancers, as well as pseudomyxoma peritonei and mesothelioma.
This successful outcome underscores the hospital’s commitment to providing state-of-the-art cancer care through advanced technology, surgical expertise, and a patient-focused approach.
Disclaimer: This news article is based solely on information provided in a press release issued by Malla Reddy Narayana Cancer Hospital dated April 21. While efforts have been made to report accurately, this article reflects the information as presented by the source.
https://theprint.in/ani-press-releases/first-of-its-kind-case-in-india-malla-reddy-narayana-cancer-hospital-successfully-treats-primary-peritoneal-ewings-sarcoma-with-advanced-hipec-surgery/2597674/
